85. Idiopathic interstitial pneumonia Clinical trials / Disease details
Clinical trials : 627 / Drugs : 443 - (DrugBank : 120) / Drug target genes : 99 - Drug target pathways : 212
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02594839 (ClinicalTrials.gov) | February 2013 | 1/11/2015 | Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease | A Phase I-II Study to Evaluate Safety and Efficacy of Allogeneic Bone-Marrow Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease | Idiopathic Interstitial Pneumonia;Interstitial Lung Disease;Idiopathic Pulmonary Fibrosis | Drug: Bone marrow mesenchymal stem cells;Drug: Placebo | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | NULL | Completed | 20 Years | 80 Years | All | 20 | Phase 1/Phase 2 | Russian Federation |